FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to medical diagnostics. In studying genotype of leprosy patients, blood is analysed for haplotype of genotype HLA DRB1-13-DQA1-0102-DQB1-0602\08, and if observed, recurrence risk is predicted.
EFFECT: there is disclosed method for prediction of recurrent leprosy risk.
1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTING SERIOUS COURSES OF LEPROTIC POLYNEURITES | 2007 |
|
RU2350955C1 |
| METHOD OF ESTIMATION OF LEPROSY RELAPSE RISK GROUP | 1993 |
|
RU2082979C1 |
| METHOD OF PROGNOSING RECURRENCE OF LEPRIC LEPROSY | 0 |
|
SU1139415A1 |
| METHOD FOR PREDICTION OF CLINICAL OUTCOME OF EXTRACORPOREAL FERTILISATION AND EMBRYO TRANSFER | 2011 |
|
RU2474822C1 |
| METHOD FOR ASSESSING THE RISK OF FORMATION OF ANTI-HLA ANTIBODIES DURING TRANSFUSION OF BLOOD COMPONENTS | 2022 |
|
RU2793843C1 |
| METHOD FOR PREDICTION OF POLLEN BRONCHIAL ASTHMA | 2010 |
|
RU2441242C1 |
| METHOD FOR PROGNOSTICATION OF LEPROUS PROCESS RELAPSE | 0 |
|
SU1636717A1 |
| METHOD FOR DETECTING ACTIVITY OF LEPROUS PROCESS | 2002 |
|
RU2231065C2 |
| METHOD FOR ASSESSING EFFICIENCY OF THE TREATMENT OF LEPROSY WITH POLYMERASE CHAIN REACTION | 2017 |
|
RU2688156C2 |
| METHOD FOR DIAGNOSING LEPROSIS | 2000 |
|
RU2171689C1 |
